SK Chemicals Co.,Ltd
KRX:285130.KS
49000 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 1,748,777.74 | 1,829,191.323 | 2,089,631.876 | 1,214,709.209 | 1,427,185.611 | 1,367,719.213 | 87,836.375 |
| Cost of Revenue
| 1,288,240.111 | 1,214,096.459 | 1,208,252.148 | 864,396.627 | 1,101,175.048 | 1,095,287.32 | 75,145.447 |
| Gross Profit
| 460,537.63 | 615,094.864 | 881,379.728 | 350,312.582 | 326,010.563 | 272,431.894 | 12,690.928 |
| Gross Profit Ratio
| 0.263 | 0.336 | 0.422 | 0.288 | 0.228 | 0.199 | 0.144 |
| Reseach & Development Expenses
| 130,293.651 | 100,220.12 | 85,885.573 | 65,777.943 | 68,124.831 | 60,041.213 | 4,756.155 |
| General & Administrative Expenses
| 26,292.19 | 22,914.568 | 16,687.166 | 14,701.556 | 17,852.905 | 15,745.297 | 1,306.758 |
| Selling & Marketing Expenses
| 93,975.157 | 126,689.042 | 95,724.427 | 61,599.876 | 63,110.146 | 67,968.834 | 7,429.094 |
| SG&A
| 243,954.653 | 149,603.61 | 112,411.593 | 76,301.432 | 80,963.051 | 83,714.131 | 8,735.852 |
| Other Expenses
| -2,589.523 | 134,790.46 | 127,725.936 | 101,950.213 | 96,584.863 | 1,783.549 | -1,046.919 |
| Operating Expenses
| 376,837.827 | 384,614.19 | 326,023.102 | 244,029.588 | 245,672.745 | 226,698.245 | 21,872.184 |
| Operating Income
| 83,699.803 | 230,480.673 | 555,185.91 | 106,282.994 | 80,337.818 | 45,733.649 | -9,181.256 |
| Operating Income Ratio
| 0.048 | 0.126 | 0.266 | 0.087 | 0.056 | 0.033 | -0.105 |
| Total Other Income Expenses Net
| -28,415.783 | 6,220.045 | -16,564.26 | -87,304.65 | -57,489.143 | -40,572.357 | -3,410.389 |
| Income Before Tax
| 55,284.02 | 236,700.718 | 538,621.651 | 18,978.344 | 22,848.675 | 5,161.291 | -12,591.645 |
| Income Before Tax Ratio
| 0.032 | 0.129 | 0.258 | 0.016 | 0.016 | 0.004 | -0.143 |
| Income Tax Expense
| 4,580.808 | 5,224.848 | 168,012.086 | 10,003.498 | 17,827.121 | 21,581.039 | -2,707.081 |
| Net Income
| 39,863.822 | 191,266.055 | 370,609.565 | 8,974.846 | 5,021.554 | 6,028.11 | -8,535.887 |
| Net Income Ratio
| 0.023 | 0.105 | 0.177 | 0.007 | 0.004 | 0.004 | -0.097 |
| EPS
| 2,077.3 | 9,915.2 | 18,936 | 304.69 | 255.08 | 308.52 | -436.67 |
| EPS Diluted
| 2,077.3 | 9,915.2 | 18,936 | 304.69 | 255.08 | 304.67 | -436.67 |
| EBITDA
| 196,585.18 | 340,743.15 | 638,233.154 | 211,469.591 | 169,035.423 | 136,858.731 | -2,443.164 |
| EBITDA Ratio
| 0.112 | 0.186 | 0.305 | 0.174 | 0.118 | 0.1 | -0.028 |